Tori Denman

Chromatin, Inc. provides seed and feedstock products for traditional agriculture and bio-industrial processes. The firm markets seed products under its Sorghum Partners brand, primarily the grain sorghum and forage sorghum seed types. It also delivers sorghum products for companies seeking renewable feedstock. Its service areas encompass supplying seed, contracting growers, providing agronomic support, and overseeing harvest and delivery of feedstock in the form and specifications required by bio-processors. The company was founded by Kevin Keith, Daphne Preuss and Gregory Paul Copenhaver in 2001 and is headquartered in Chicago, IL.

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

Epistrophe Ltd. engages in the provision of data processing, hosting and related services. The company was founded on January 22, 2002 and is headquartered in London, the United Kingdom.

Lansdowne Partners (UK) LLP (Lansdowne) is the alternative investment management subsidiary of Lansdowne Partners Ltd., itself a subsidiary of Lansdowne Partners International Ltd. in the Cayman Islands. The firm is headquartered in London and was founded in 1998. Lansdowne provides investment advisory services on a discretionary basis to their clients, which includes commingled investment vehicles intended for institutional investors and other sophisticated investors and investment vehicles formed for particular investors and separately managed accounts for sophisticated financial institutions, including registered investment companies. Lansdowne is a signatory to the United Nations Principles of Responsible Investing (UNPRI).

Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland.

Part of Interfor Corp., Adprotech Ltd. is a British pharmaceutical manufacturing company. The company is based in Royston, UK. Adprotech was acquired by EACOM Timber Corp., part of Interfor Corp. from November 23, 2021 on April 20, 2004 for $15.23 million.

Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom.

DisplayLink Corp. engages in the development of software compression technology. It offers universal docking stations, universal serial bus (USB) monitors, USB adapters, wireless virtual reality products, and meeting room systems. The company was founded by Martin King, Quentin Stafford-Fraser, Andrew Fisher, and Tim Glauert in 2003 and is headquartered in Palo Alto, CA.

Oxford Capital Partners LLP (Oxford Capital Partners) is a venture capital subsidiary of Oxford Capital Partners Holdings Ltd founded in 1999 by Tedd Mott and David Edward Christian Mott. The firm is headquartered in Oxford, United Kingdom.

Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.

Power Integrations UK Ltd. provides energy-efficient power conversion products. Its applications include mobile, feature, smart phones and media tablets. The company was founded by Gehan Anil Joseph Amaratunga and is headquartered in Cambridge the United Kingdom.

GAM Systematic LLP (GAMS) is an alternative investment management firm headquartered in London, UK. The firm was founded by Dr. Ewan Kirk and Erich Schlaikjer in 2006 as Cantab Capital Partners LLP. They are a subsidiary of GAM (UK) Ltd., which is owned by GAM Holding AG (SWX: GAM, ADR: GMHLY) in Switzerland. GAMS provides investment management services to a range of pooled investment vehicles, which include the GAMS Funds. Additionally, the firm may establish (and has established) separately managed accounts for institutional investors.

Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill.

GE Healthcare BV manufactures transformational medical equipment and services to healthcare sector. It markets medical imaging, information technologies, medical diagnostics and patient monitoring systems. The company is headquartered in Hoevelaken, the Netherlands.

The British Private Equity & Venture Capital Association (BVCA) was founded in 1983 and is based in London, UK. The BVCA is the voice of private capital in the UK and supports its members to help companies grow and achieve their long-term ambitions, creating value for the country both economically and socially. The BVCA provides information on private equity and venture capital, institutional investors, ESG and responsible investment, diversity and inclusion, and policy. The BVCA also conducts research, publishes reports, and hosts events. The BVCA's mission is to promote diversity and inclusion within the industry and support firms to build inclusive environments in which everyone can thrive.

True North Management Partners LLC (True North Venture) is a venture capital firm founded in 2011 by Michael Ahearn, Matt Scott Ahearn and Eugene J. Huang. The firm is headquartered in Chicago, Illinois.

Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom.

Audio Analytic Ltd. produces sound recognition and analysis software. The firm offers ai3 which recognizes a number of sounds from window glass break, dog bark, smoke and CO alarm, baby cry to anomaly detection. The company was founded by Christopher Mitchell in 2010 and is headquartered in Cambridge, the United Kingdom.

Xfund Management Co. LLC (Xfund) is a venture capital firm founded in 2011 by Hugo van Vurren. The firm is headquartered in Palo Alto, California.

The Cambridge Arts Theatre Trust Ltd. operates as a theatre that presents a varied mix of drama, dance, opera and pantomime. The company was founded on March 27, 1998 and is headquartered in Cambridge, the United Kingdom.

Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.

Malibu IQ LLC focuses on commercialization of defense, aerospace, and automotive technologies to develop new products. It caters to electronics, energy, life sciences, networking, and communications sectors. The company was founded by David Moxam, Gregory Kovacs and Sha-Chelle Devlin Manning and is headquartered in Covington, LA.

Origami Energy Ltd. develops and commercializes a technology platform for distributed energy applications. It offers technology and solutions to connect, control and manage a network of existing energy generating and energy storing assets connected to the electricity grid. The company was founded by Peter Bance in 2013 and is headquartered in London, the United Kingdom.

CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom.

Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom.

Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom.

Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom.

Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom.

Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom.